Cargando…
Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: a prospective study
BACKGROUND: Anti-programmed cell death-1 (PD-1) antibodies can cause thyroid dysfunction. However, no predictive biomarkers enabling stratification of thyroid dysfunction risk have been identified. METHODS: A total of 209 patients treated with an anti-PD-1 antibody were evaluated for anti-thyroid an...
Autores principales: | Okada, Norio, Iwama, Shintaro, Okuji, Takayuki, Kobayashi, Tomoko, Yasuda, Yoshinori, Wada, Eri, Onoue, Takeshi, Goto, Motomitsu, Sugiyama, Mariko, Tsunekawa, Taku, Takagi, Hiroshi, Hagiwara, Daisuke, Ito, Yoshihiro, Suga, Hidetaka, Banno, Ryoichi, Hase, Tetsunari, Morise, Masahiro, Kanda, Mitsuro, Yokota, Kenji, Hashimoto, Naozumi, Ando, Masahiko, Fujimoto, Yasushi, Nagino, Masato, Kodera, Yasuhiro, Fujishiro, Mitsuhiro, Hibi, Hideharu, Sone, Michihiko, Kiyoi, Hitoshi, Gotoh, Momokazu, Ando, Yuichi, Akiyama, Masashi, Hasegawa, Yoshinori, Arima, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078193/ https://www.ncbi.nlm.nih.gov/pubmed/32009131 http://dx.doi.org/10.1038/s41416-020-0736-7 |
Ejemplares similares
-
Patients With Antithyroid Antibodies Are Prone To Develop Destructive Thyroiditis by Nivolumab: A Prospective Study
por: Kobayashi, Tomoko, et al.
Publicado: (2018) -
Pituitary dysfunction induced by immune checkpoint inhibitors is associated with better overall survival in both malignant melanoma and non-small cell lung carcinoma: a prospective study
por: Kobayashi, Tomoko, et al.
Publicado: (2020) -
Anti-tumor effects of anti-programmed cell death-1 antibody treatment are attenuated in streptozotocin-induced diabetic mice
por: Ito, Masaaki, et al.
Publicado: (2023) -
SUN-062 Randomized Controlled Trial for Assessment of the Effects of Anaglipitin, a DPP-4 Inhibitor, on Blood Lipids in Type 2 Diabetic Patients
por: Onoue, Takeshi, et al.
Publicado: (2019) -
Anti-pituitary antibodies and susceptible human leukocyte antigen alleles as predictive biomarkers for pituitary dysfunction induced by immune checkpoint inhibitors
por: Kobayashi, Tomoko, et al.
Publicado: (2021)